Literature DB >> 1586591

Intraperitoneal cytostatics impair early post-operative collagen synthesis in experimental intestinal anastomosesP6.

M F Martens1, T Hendriks, T Wobbes, J J De Pont.   

Abstract

Collagen synthesis in intestinal anastomoses has been measured in rats after in vivo administration of cytostatics. The cytostatics were administered during 5 consecutive days either intravenously or intraperitoneally. On day 3 of the course the rats received both an ileal and a colonic anastomosis. The animals were sacrificed 3 and 7 days after operation. The cytostatics regimen used was a combination of 5-fluorouracil, bleomycin and cisplatinum in a dose of 10, 2 and 0.35 mg kg-1 day-1, respectively. In an additional group, a twice higher dose was given intraperitoneally. Three days after operation a severe inhibition of the collagen synthesis was observed in all the cytostatics treated groups, both in ileum and in colon. The effects of intraperitoneal administration were much more pronounced than those observed after an equal dose given intravenously. Seven days after operation the collagen synthesis in the intravenously treated groups was restored to the level of the control group. However, in the intraperitoneal groups the collagen synthesis in ileal anastomoses was still inhibited. Thus, cytostatics suppress collagen synthesis in intestinal anastomoses. The effect is more severe after intraperitoneal than after intravenous administration, confirming our earlier hypothesis that the former mode of administration comprises a higher risk for anastomotic integrity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586591      PMCID: PMC1977395          DOI: 10.1038/bjc.1992.139

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

Review 1.  The effect of antineoplastic agents on wound healing.

Authors:  M K Ferguson
Journal:  Surg Gynecol Obstet       Date:  1982-03

2.  Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer.

Authors:  R L Dedrick; C E Myers; P M Bungay; V T DeVita
Journal:  Cancer Treat Rep       Date:  1978-01

3.  The scientific basis for adjuvant chemotherapy.

Authors:  D S Martin
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

4.  Healing of experimental colonic anastomoses. III. Collagen metabolism in the colon after left colon resection.

Authors:  H Jiborn; J Ahonen; B Zederfeldt
Journal:  Am J Surg       Date:  1980-03       Impact factor: 2.565

5.  Anastomotic integrity after operations for large-bowel cancer: a multicentre study.

Authors:  L P Fielding; S Stewart-Brown; L Blesovsky; G Kearney
Journal:  Br Med J       Date:  1980-08-09

6.  Histological features of wound repair: a comparison between experimental ileal and colonic anastomoses.

Authors:  W L Hesp; T Hendriks; P H Schillings; E J Lubbers; H H de Boer
Journal:  Br J Exp Pathol       Date:  1985-10

7.  The genetic origin of drug resistance in neoplasms: implications for systemic therapy.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Res       Date:  1984-09       Impact factor: 12.701

8.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

Authors:  J H Goldie; A J Coldman
Journal:  Cancer Treat Rep       Date:  1979 Nov-Dec

9.  A randomized controlled trial of adjuvant portal vein cytotoxic perfusion in colorectal cancer.

Authors:  I Taylor; D Machin; M Mullee; G Trotter; T Cooke; C West
Journal:  Br J Surg       Date:  1985-05       Impact factor: 6.939

10.  Biochemical characterization of collagens synthesized by intestinal epithelial cell cultures.

Authors:  A Quaroni; R L Trelstad
Journal:  J Biol Chem       Date:  1980-09-10       Impact factor: 5.157

View more
  8 in total

1.  The integrity of colonic anastomoses following the intraperitoneal administration of oxaliplatin.

Authors:  Konstantinos Blouhos; Manousos-Georgios Pramateftakis; Theodor Tsachalis; Dimitrios Kanellos; Thomas Zaraboukas; Georgios Koliakos; Dimitrios Betsis
Journal:  Int J Colorectal Dis       Date:  2010-03-09       Impact factor: 2.571

2.  Therapeutic improvement of colonic anastomotic healing under complicated conditions: A systematic review.

Authors:  Malene Nerstrøm; Peter-Martin Krarup; Lars Nannestad Jorgensen; Magnus S Ågren
Journal:  World J Gastrointest Surg       Date:  2016-05-27

3.  Healing of colonic anastomoses after immediate postoperative intraperitoneal administration of oxaliplatin.

Authors:  Dimitrios Kanellos; Manousos-Georgios Pramateftakis; Haralampos Demetriades; Emmanouil Zacharakis; Stamatios Angelopoulos; Ioannis Mantzoros; Ioannis Kanellos; Kalliopi Despoudi; Thomas Zaraboukas; Georgios Koliakos; Kalliopi Galovatsea; Haralampos Lazaridis
Journal:  Int J Colorectal Dis       Date:  2008-08-02       Impact factor: 2.571

4.  Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study.

Authors:  W Graf; J E Westlin; L Påhlman; B Glimelius
Journal:  Int J Colorectal Dis       Date:  1994-04       Impact factor: 2.571

5.  Early post-operative 5-fluorouracil does not affect the healing of experimental intestinal anastomoses.

Authors:  J W de Waard; T Wobbes; T Hendriks
Journal:  Int J Colorectal Dis       Date:  1993-09       Impact factor: 2.571

6.  Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?

Authors:  B M van der Kolk; B M de Man; T Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

7.  Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents. Implications for wound healing.

Authors:  T Hendricks; M F Martens; C M Huyben; T Wobbes
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

8.  Post-operative levamisole may compromise early healing of experimental intestinal anastomoses.

Authors:  J W de Waard; T Wobbes; B M de Man; C J van der Linden; T Hendriks
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.